News | May 18, 2025
Briefs: Dr. Reddy's Laboratories, Relonchem, Shilpa Pharma Lifesciences and Shanmuga Hospital
Shilpa Pharma Lifesciences, Unit-1, received EIR from USFDA
Shilpa Pharma Lifesciences, Unit-1, received EIR from USFDA
CuraTeQ Biologics receives approval for biosimilar Zefylti from UK’s MHRA
The inspection conducted from December 16, 2024 to December 20, 2024 by the Brazil Health Regulatory Agency (ANVISA)
This marks yet another milestone in our series of successful audits over the past year
These observations are procedural in nature and none of them are related to data integrity
The inspection concluded with 6 observations and none of them were related to Data Integrity
Raichur site is the group’s largest API facility and part of a wider network of seven sites
The inspection has concluded with four observations
Alkem Medtech to acquire 100% stake of Bombay Ortho
USFDA inspection at Alembic Pharma's Bioequivalence facility
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
